199 related articles for article (PubMed ID: 859104)
1. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
Heffner TG; Zigmond MJ; Stricker EM
J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
[TBL] [Abstract][Full Text] [Related]
2. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats.
Heffner TG; Seiden LS
J Pharmacol Exp Ther; 1979 Jan; 208(1):134-43. PubMed ID: 759608
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
4. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
6. [Dopamine sensitivity of brain-induced behavior after repeated administration of dopamine agonists and antagonists].
Westermann KH; Schmidt J
Biomed Biochim Acta; 1984; 43(7):1027-32. PubMed ID: 6517885
[TBL] [Abstract][Full Text] [Related]
7. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
[TBL] [Abstract][Full Text] [Related]
8. The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior.
Zigmond MJ; Heffner TG; Stricker EM
Prog Neuropsychopharmacol; 1980; 4(4-5):351-62. PubMed ID: 7220661
[No Abstract] [Full Text] [Related]
9. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
10. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
[TBL] [Abstract][Full Text] [Related]
11. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.
Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507
[TBL] [Abstract][Full Text] [Related]
12. Actions of dopaminergic agonists on motor function.
Costall B; Naylor RJ
Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
[No Abstract] [Full Text] [Related]
13. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
Hollister AS; Breese GR; Mueller RA
J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
[TBL] [Abstract][Full Text] [Related]
14. Sedative action of low doses of dopaminergic agents.
Maj J; Przewlocka B; Kukulka L
Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
[TBL] [Abstract][Full Text] [Related]
15. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
[TBL] [Abstract][Full Text] [Related]
16. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
[TBL] [Abstract][Full Text] [Related]
17. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Chopin P; Colpaert FC; Marien M
J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
[TBL] [Abstract][Full Text] [Related]
19. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
Heidenreich BA; Mailman RB; Nichols DE; Napier TC
J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
[TBL] [Abstract][Full Text] [Related]
20. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Kulkarni SK; Dandiya PC
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
